Coronary risk factors: New perspectives

International Journal of Epidemiology

Volumn 30, Issue SUPPL. 1, 2001, Pages

  Niccoli, Giampaolo ^a   Iacoviello, Licia ^b   Cianflone, Domenico ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Consorzio Mario Negri Sud ^*  (Italy)

Author keywords

C reactive protein; Genotype; Myocardial infarction; Risk factors

Indexed keywords

CARDIOVASCULAR DISEASE;

ACUTE HEART INFARCTION; ARTERY THROMBOSIS; ARTICLE; CLINICAL GENETICS; CONTROLLED STUDY; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DATA BASE; DISEASE CONTROL; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FUTUROLOGY; GENOTYPE; HEART DISEASE; HUMAN; INCIDENCE; INDIVIDUALITY; ISCHEMIC HEART DISEASE; MARKER GENE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; POPULATION RESEARCH; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SENSIBILITY; TREATMENT PLANNING;

EID: 0034767072     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/30.suppl_1.S41     Document Type: Article

References (65)

1. Increasing burden of cardiovascular disease: Current knowledge and future directions for research on risk factors
2. Current concepts: Primary prevention of myocardial infarction
3. Angiographic finding 1 month after myocardial infarction, a prospective study of 259 survivors
4. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361 662 men
5. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary artery disease. Overall findings and differences by age for 316 099 white men
6. The value of lowering cholesterol after myocardial infarction
7. An analysis of randomized trials evaluating the effects of cholesterol reduction on total mortality and coronary heart disease incidence
8. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease
9. Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General
10. The risk of myocardial infarction after quitting smoking in men under 55 years of age
11. The association of glycemia and cause-specific mortality in a diabetic population
12. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus
13. The pathogenesis of cardiovascular disease: Role of the endothelium as a target and mediator
14. Endothelial function as an endpoint in interventional trial: Concepts, methods and current data
15. The pathogenesis of atherosclerosis-an update
16. Comparison of coronary angiographic narrowing in stable angina pectoris, unstable angina pectoris and in acute myocardial infarction
17. Coronary vasospasm as a possible cause of myocardial infarction: A conclusion derived from the study of 'preinfarction' angina
18. Coronary artery spasm and coronary vasoconstriction: The case for a distinction
19. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
20. Elevation of C-reactive protein in acute coronary disease
21. Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis. CAPTURE Investigators. Chimeric cTE3 antiplatelet therapy in unstable angina refractory to standard treatment trial
22. C-reactive protein is a potent predictor of mortality indipendently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy
23. Inducible endothelial functions in inflammation and coagulation
24. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina
25. Molecular bases of the acute coronary syndromes
26. Final report on the aspirin component of the ongoing Physicians Health Study
27. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial
28. The Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: Randomized trial of low-intensity anticoagulation with warfarin and low-dose aspirin in the primary disease in men at increased risk
29. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project
30. Cholesterol and mortality. 30 years of follow up from the Framingham Study
31. Lipoprotein (a): A genetic risk factor for premature coronary heart disease
32. Hyperhomocysteinemia: An indipendent risk factor for vascular disease
33. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians
34. Chlamydia pneumoniae specific circulating immune complexes in patients with chronic coronary heart disease
35. Helicobacter pylori infection: Relation with cardiovascular risk factors, ischemic heart disease and social class
36. Helicobacter pylori infection and mortality from ischemic heart disease: Negative result from a large prospective study
37. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromicin in male survivors of myocardial infarction
38. Does atherosclerosis have an infective aetiology?
39. Cytomegalovirus replication is not a cause of instability in unstable angina
40. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: Roxis Pilot Study
41. Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies
42. Blood levels of homocysteine and increased risk of cardiovascular disease. Causal or casual?
43. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies
44. Plasma concentration of soluble intercellular adhesion molecule 1 and the risk of future myocardial infarction in apparently healthy men
45. Changes of serum antibodies to heat shock protein 65 in coronary heart disease and acute myocardial infarction
46. Haemostatic function and ischemic heart disease: Principal results of the Northwich Park Heart Study
47. Recombinant interleukin-6 regulates the transcriptional activation of a set of human acute phase genes
48. Inflammation, aspirin and risks of cardiovascular disease in apparently healthy men
49. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case control study
50. Lipoprotein-associated phospholipase A2 as an indipendent predictor of coronary heart disease
51. Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease
52. Production of C-reactive protein and risk of coronary events in stable and unstable angina
53. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
54. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease
55. Evaluating novel cardiovascular risk factor: Can we better predict heart attacks?
56. Gene environment interactions: Implications for cardiovascular disease
57. Helicobacter pylori infection and the risk of myocardial infarction: Role of fibrinogen and its genetic control
58. 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: A model of gene-environment interaction
59. Prothrombotic genetic risk factors in young survivors of myocardial infarction
60. Inflammation, Pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
61. Inter-university Cardiology Institute, Utrecht, The Netherlands, Regression Growth Evaluation Statin Study
62. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
63. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction
64. Cigarette smoking doubles the risk of myocardial infarction in carriers of a protective polymorphism in the blood coagulation factor VII gene
65. Declining mortality in coronary heart disease